Skip to Main Content
Our Commitment to Diversity

Life Sciences

Advancements in maintaining and improving the quality of life are predicated on the research and development embarked on by participants in the life sciences industry. These participants—from pharmaceutical and biotechnology companies, to academic and research institutions, to medical device manufacturers and food processors—span the gamut of business life cycle stages. 

Whether an emerging business or an established multinational corporation, our Life Sciences lawyers offer a full spectrum of legal services to assist life sciences companies and their products at any stage, as well as to the venture capital and private equity funds that support them.

Our lawyers possess an impressive complement of pharmaceutical, diagnostic, and medical device-related business experience and a deep technical background in molecular biology and chemistry. Several of our Life Sciences lawyers were once themselves executives in life science companies.

With a global, multidisciplinary Life Sciences team, we have experience solving the complex legal and regulatory issues facing life sciences companies such as:

  • Intellectual property, including Freedom to Operate analysis; due diligence; patent preparation, prosecution, and protection; trademarks and copyrights; and IP litigation.
  • Licensing and partnering arrangement negotiations, including technology transfer; research and development licenses; joint venture; marketing, supply, and distribution; and merger. 
  • U.S. Food and Drug Administration and other regulatory compliance, including preparing submissions and responding to enforcement matters.
  • Drug pricing and market access, including government price reporting, policy drafting, and 340B counsel; negotiating rebate, specialty pharmacy, and payer rebate agreements; and copay card and PAP compliance.
  • Mergers and acquisitions, including stock and asset acquisitions; traditional mergers; tender offers; leveraged buyouts; spin-offs; spinouts; recapitalizations; and venture funding.
  • Capital markets, including preparation of admission documents, registration statements and prospectuses, negotiation of underwriting and placement terms, and preparation of listing applications for stock exchanges.
  • Human resources, including confidentiality agreements and executive compensation.
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel